摘要:
Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要:
Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity HPV31 L1 total rebuild nucleotide and amino acid sequence: M S L W R P S 1 ATGTCTTTGT GGAGACCATC E A T V Y L P P V P TGAAGCTACC GTCTACTTGC CACCAGTCCC V S K V V S T 51 AGTCTCTAAG GTCGTCTCTA D E Y V T R T N I Y CCGACGAATA CGTCACCAGA ACCAACATCT Y H A G S A 101 ACTACCACGC TGGTTCTGCT R L L T V G H P Y Y AGATTGTTGA CCGTCGGTCA CCCATACTAC S I P K S D N 151 TCTATCCCAA AGTCTGACAA P K K I V V P K V S CCCAAAGAAG ATCGTCGTCC CAAAGGTCTC G L Q Y R V F 201 TGGTTTGCAA TACAGAGTCT R V R L P D P N K F TCAGAGTCAG ATTGCCAGAC CCAAACAAGT G F P D T S 251 TCGGTTTCCC AGACACCTCT F Y N P E T Q R L V TTCTACAACC CAGAAACCCA AAGATTGGTC W A C V G L E 301 TGGGCTTGTG TCGGTTTGGA V G R G Q P L G V G AGTCGGTAGA GGTCAACCAT TGGGTGTCGG I S G H P L L 351 TATCTCTGGT CACCCATTGT N K F D D T E N S N TGAACAAGTT CGACGACACC GAAAACTCTA R Y A G G P 401 ACAGATACGC TGGTGGTCCA G T D N R E C I S M GGTACCGACA ACAGAGAATG TATCTCTATG D Y K Q T Q L 451 GACTACAAGC AAACCCAATT C L L G C K P P I G GTGTTTGTTG GGTTGTAAGC CACCAATCGG E H W G K G S 501 TGAACACTGG GGTAAGGGTT P C S N N A I T P G CTCCATGTTC TAACAACGCT ATCACCCCAG D C P P L E 551 GTGACTGTCC ACCATTGGAA L K N S V I Q D G D TTGAAGAACT CTGTCATCCA AGACGGTGAC N V D T G F G 601 ATGGTCGACA CCGGTTTCGG A N D F T A L Q D T TGCTATGGAC TTCACCGCTT TGCAAGACAC K S W V P L D 651 CAAGTCTAAC GTCCCATTGG I C N S I C K Y P D ACATCTGTAA CTCTATCTGT AAGTACCCAG Y L K M V A 701 ACTACTTGAA GATGGTCGCT E P Y G D T L F F Y GAACCATACG GCGACACCTT GTTCTTCTAC L R R E Q M F 751 TTGCGTAGAG AACAGATGTT V R H F F N R S G T CGTAAGGCAC TTCTTCAACA GATCCGGCAC V G E S V P T 801 CGTAGGTGAA TCTGTCCCAA D L Y I K G S G S T CCGACCTGTA CATCAAGGGC TCCGGTTCCA A T L A N S 851 CCGCTACCCT GGCTAACTCC T Y F P T P S G S N ACCTACTTCC CAACTCCATC TGGCTCCATG V T S D A Q I 901 GTCACCTCCG ACGCTCAGAT F N K P Y W M Q R A CTTCAACAAG CCATACTGGA TGCAGCGTGC Q G H N N G I 951 ACAGGGTCAC AACAACGGTA C W G N Q L F V T V TCTGTTGGGG TAACCAGCTG TTCGTGACTG V D T T R S 1001 TGGTCGATAC CACGCGTTCT T N N S V C A A I A ACCAACATGT CTGTCTGTGC TGCAATCGCT N S D T T F K 1051 AACTCTGACA CTACCTTCAA S S N F K E Y L R H GTCCTCTAAC TTCAAGGAGT ACCTGAGACA G E E F D L Q 1101 TGGTGAGGAA TTCGATCTGC F I F Q L C K I T L AATTCATCTT CCAGTTGTGC AAGATCACCC S A D I N T 1151 TGTCTGCTGA CATCATGACC Y I H S M N P A I L TACATCCACA GTATGAACCC TGCCATCCTG E D W N F G L 1201 GAGGACTGGA ACTTCGGTCT T T P P S G S L E D GACCACTCCA CCTTCCGGTT CTTTGGAAGA.
摘要:
Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要:
Recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins and purified virus-like particles comprised of the recombinant proteins are provided.
摘要:
Disclosed is a process for increasing the yield of disulfide bonded recombinant proteins produced by yeast, especially recombinant secreted proteins The enzyme protein disulfide isomerase (PDI) catalyzes the formation of disulfide bonds in secretory and cell-surface proteins. We disclose the construction of recombinant strains of the yeast Saccharomyces cerevisiae which overproduce either human PDI or yeast PDI in a regulated fashion. These strains show greatly increased secretion of disulfide bonded proteins of potential therapeutic significance. These strains have the potential to increase the production of various disulfide bonded proteins.
摘要:
Lyophilization time of live viral compositions is reduced and output per lyophilization unit is increased by lyophilizing a reduced volume of a more concentrated viral composition.
摘要:
An improved stabilized liquid live viral vaccine contains a live virus, partially hydrolyzed gelatin, a monosaccharide or disaccharide, a cell culture medium, L-glutamic acid, L-arginine and sufficient physiologically acceptable acidic buffer to maintain the pH at from about 6.0 to about 6.5.
摘要:
Hepatitis A virus is harvested from persistently infected cells, the cells are then trypsinized, replanted and a second harvest of hepatitis A virus is obtained. The cells can be trypsinized and replanted and harvested indefinitely.
摘要:
Automated tests to evaluate the antibody titer of a sample by incubating a test sample, bacteria, and complement, and detecting bacterial growth in the incubated mixture, and to identify bacteria and its titer in a sample by incubating a test sample, bacterial antiserum, and complement, and detecting inhibition of bacterial growth in the incubated mixture. The automated tests lend themselves to diagnostic use and may be provided in the form of diagnostic test kits.